一种新的治疗规划方法通过剪刀束用于均目标剂量质子GRID,具有峰值-谷-剂量比率优化
Weijie Zhang1, Erik Traneus2, Yuting Lin1
1Department of Radiation Oncology, University of Kansas Medical Center, Kansas City, USA.
Medical physics
|July 15, 2024
概括
这项研究引入了剪刀束 (SB) 用于均目标剂量 (UTD) 质子GRID疗法,优化剂量分配以减少正常组织损伤. 新的SB-TVL1方法提高了峰值谷剂量比 (PVDR) 以改善质子空间分离RT (SFRT).
科学领域:
- 医学物理和辐射瘤学.
- 开发新的放射治疗技术.
- 在治疗规划中的计算方法.
背景情况:
- 质子空间分离RT (SFRT) 利用布拉格峰值特性和峰值谷剂量比 (PVDR) 来最大限度地减少正常组织损伤.
- 均目标剂量 (UTD) 质子GRID提供了临床优势,因为它与传统的质子RT剂量分布相似.
- 缺乏有效的治疗规划方法目前阻碍了UTD质子GRID的临床采用.
研究的目的:
- 为UTD质子GRID开发一种使用剪刀束 (SB) 的新型治疗规划方法.
- 为了实现PVDR和剂量目标的联合优化,以改善放射治疗规划.
主要方法:
- 该SB方法涉及一个初级光束 (PB) 分为两半,交错的光束用于空间剂量调制和一个补充光束 (CB) 确保UTD,同时保持调制.
- 为了PVDR和剂量目标优化,开发了一种结合关节总变化和L1 (TVL1) 调节的治疗规划方法.
- 用一个代凸放松算法来解决计划优化.
主要成果:
- 通过SB方法,在UTD的正常组织中证明了调制的空间剂量模式,并与传统的质子RT (CONV) 具有可比的平面质量.
- 与SB相比,SB-TVL1方法进一步最大化了PVDR,同时保持了可比的剂量体积参数.
- 验证证实了SB和SB-TVL1与CONV.相比的有效性.
结论:
- 一种新的SB方法使UTD质子GRID在正常组织中实现调制的空间剂量模式.
- 开发的基于TVL1调节的规划方法允许在质子GRID疗法中联合优化PVDR和剂量目标.
更多相关视频
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
20.3K
07:57Positron Emission Tomography-based Dose Painting Radiation Therapy in a Glioblastoma Rat Model using the Small Animal Radiation Research Platform
Published on: March 24, 2022
2.8K
相关概念视频
01:15Drug Dosage Regimen: Overview
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
01:28Dosage Regimens: Designs and Approaches
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
01:24Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.